• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging roles for pharmacists in performance-based risk-sharing arrangements.

作者信息

Calabrese Martin J, Cooke Catherine E, Watson Kristin, de Bittner Magaly Rodriguez

机构信息

Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD.

出版信息

Am J Health Syst Pharm. 2017 Jul 1;74(13):1007-1012. doi: 10.2146/ajhp160398. Epub 2017 May 18.

DOI:10.2146/ajhp160398
PMID:28522641
Abstract
摘要

相似文献

1
Emerging roles for pharmacists in performance-based risk-sharing arrangements.药剂师在基于绩效的风险分担安排中的新角色。
Am J Health Syst Pharm. 2017 Jul 1;74(13):1007-1012. doi: 10.2146/ajhp160398. Epub 2017 May 18.
2
[Innovating in pharmaceutical expenditure management: from payment per product to payment for health outcomes].[创新药品支出管理：从按产品付费到按健康结果付费]
Rev Esp Salud Publica. 2013 Jul-Aug;87(4):303-6. doi: 10.4321/S1135-57272013000400001.
3
Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.基于绩效的风险分担安排——设计、实施和评估的良好实践：ISPOR 基于绩效的风险分担安排良好实践工作组的报告。
Value Health. 2013 Jul-Aug;16(5):703-19. doi: 10.1016/j.jval.2013.04.011. Epub 2013 Jul 19.
4
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.医疗保健支付方与医疗产品制造商之间基于绩效的风险分担安排的现状与趋势
Appl Health Econ Health Policy. 2014 Jun;12(3):231-8. doi: 10.1007/s40258-014-0093-x.
5
Where are we on "risk-sharing" agreements?我们在“风险分担”协议方面进展如何？
Value Health. 2013 Jul-Aug;16(5):701-2. doi: 10.1016/j.jval.2013.04.012. Epub 2013 Jun 14.
6
[Innovative agreements with the pharmaceutical industry: "pay for performance"].与制药行业的创新协议：“按绩效付费”
Farm Hosp. 2010 Mar-Apr;34(2):53-5. doi: 10.1016/j.farma.2009.12.004. Epub 2010 Mar 6.
7
Financial valuation of incentive arrangements in managed care contracts: a real options approach.管理式医疗合同中激励安排的财务估值：一种实物期权方法。
J Health Care Finance. 2001 Fall;28(1):39-60.
8
AMCP Pay-for-Performance Principles: Performance-Based Reimbursement and Direct and Indirect Remuneration (DIR) Fees.AMCP 按效付费原则：基于绩效的报销和直接及间接报酬（DIR）费用。
J Manag Care Spec Pharm. 2022 Feb;28(2):138-144. doi: 10.18553/jmcp.2022.28.2.138.
9
How to Hit a Home Run with Bundled Payments.如何通过捆绑支付实现大获成功。
Consult Pharm. 2015 Sep;30(9):492-504. doi: 10.4140/TCP.n.2015.492.
10
Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.药剂师对通过药剂师开处方管理高血压的绩效薪酬与按服务收费薪酬的看法。
Int J Pharm Pract. 2017 Oct;25(5):388-393. doi: 10.1111/ijpp.12330. Epub 2017 Jan 18.

引用本文的文献

1
Barriers and Opportunities for Implementation of Outcome-Based Spread Payments for High-Cost, One-Shot Curative Therapies.高成本一次性治愈性疗法实施基于结果的推广支付的障碍与机遇
Front Pharmacol. 2020 Dec 8;11:594446. doi: 10.3389/fphar.2020.594446. eCollection 2020.